Although it appears that celastrol prevents and treats obesity through distinct pathways, the evidence that obese mice treated with celastrol lose weight even when their food intake is equalized to that of controls suggest that celastrol may activate the HSF1 pathway and increase energy expenditure also in obese states. This evidence concerns the gene HSF1 and obesity due to melanocortin 4 receptor deficiency.